Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria
- PMID: 10546021
- DOI: 10.2337/diacare.22.11.1865
Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria
Abstract
Objective: Using von Willebrand Factor (vWF) as a marker of endothelial function, previous studies have shown that the development of microalbuminuria is associated with the onset of endothelial dysfunction in individuals with type 2 diabetes. We tested the hypothesis that endothelial dysfunction is already evident in normoalbuminuric individuals with type 2 diabetes.
Research design and methods: We used laser Doppler imaging scanning to measure vasodilation in the forearm skin in response to iontophoresis of 1% acetylcholine (endothelium-dependent) and 1% sodium nitroprusside (endothelium-independent). Multiple indicators of endothelial function--soluble intercellular adhesion molecule (sICAM), soluble vascular cell adhesion molecule (sVCAM), vWF, and microvascular reactivity--were measured in 20 healthy control subjects, 45 normoalbuminuric (urinary albumin/creatinine ratio < 30 micrograms/mg) individuals with type 2 diabetes, and 14 microalbuminuric (urinary albumin/creatinine ratio between 30 and 300 micrograms/mg) individuals with type 2 diabetes.
Results: Serum sICAM and sVCAM levels were elevated in the normoalbuminuric (305 +/- 120, 851 +/- 284 ng/ml) and microalbuminuric (300 +/- 89, 845 +/- 252 ng/ml) individuals with diabetes when compared with the healthy control subjects (213 +/- 58, 661 +/- 176 ng/ml) (P < 0.01). Furthermore, the microvascular endothelium-dependent and -independent vasodilation was reduced in the normoalbuminuric (76 +/- 44, 70 +/- 33) (percent increase in perfusion over baseline) and microalbuminuric (74 +/- 41, 73 +/- 28) individuals with diabetes compared with healthy control subjects (126 +/- 67, 120 +/- 47) (P < 0.05). In contrast, plasma vWF was elevated only in the microalbuminuric individuals with diabetes (129 +/- 35%) compared with the normoalbuminuric individuals with diabetes (110 +/- 34) and healthy control subjects (111.3 +/- 39) (P < 0.05). On stepwise multivariate analysis, fasting blood glucose was the most important contributing factor to the variation in microvascular reactivity and sVCAM, whereas insulin resistance (by homeostasis model assessment) was the most important contributing factor to the variation in sICAM. Addition of all clinical and biochemical measures explained only 15-22% of the variation in sICAM, sVCAM, and microvascular reactivity.
Conclusions: Multiple markers of endothelial dysfunction were evident in normoalbuminuric individuals with type 2 diabetes. The pathogenic process of vasculopathy in type 2 diabetes occurs early and may be operative before the development of microalbuminuria.
Similar articles
-
Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes.Diabetes. 1999 Sep;48(9):1856-62. doi: 10.2337/diabetes.48.9.1856. Diabetes. 1999. PMID: 10480619
-
Insulin resistance and endothelial dysfunction in type 2 diabetes patients with or without microalbuminuria.Diabetes Res Clin Pract. 2004 Aug;65(2):95-104. doi: 10.1016/j.diabres.2004.01.006. Diabetes Res Clin Pract. 2004. PMID: 15223221
-
The effect of hormonal replacement therapy on the vascular reactivity and endothelial function of healthy individuals and individuals with type 2 diabetes.J Clin Endocrinol Metab. 1999 Nov;84(11):4159-64. doi: 10.1210/jcem.84.11.6160. J Clin Endocrinol Metab. 1999. PMID: 10566666
-
Deciphering Endothelial Dysfunction in the HIV-Infected Population.Adv Exp Med Biol. 2019;1134:193-215. doi: 10.1007/978-3-030-12668-1_11. Adv Exp Med Biol. 2019. PMID: 30919339 Review.
-
Angiogenesis outcomes of metformin utilization in diabetes mellitus: a systematic review and meta-analysis.J Pak Med Assoc. 2024 Jun;74(6 (Supple-6)):S34-S40. doi: 10.47391/JPMA.S6-ACSA-07. J Pak Med Assoc. 2024. PMID: 39018137
Cited by
-
Endothelial dysfunction, inflammation, and insulin resistance: a focus on subjects at risk for type 2 diabetes.Curr Diab Rep. 2004 Aug;4(4):237-46. doi: 10.1007/s11892-004-0074-9. Curr Diab Rep. 2004. PMID: 15265464 Review.
-
Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment.Rev Diabet Stud. 2013 Summer-Fall;10(2-3):133-56. doi: 10.1900/RDS.2013.10.133. Epub 2013 Aug 10. Rev Diabet Stud. 2013. PMID: 24380089 Free PMC article. Review.
-
Circulating endothelial cells and chronic kidney disease.Biomed Res Int. 2014;2014:364738. doi: 10.1155/2014/364738. Epub 2014 May 18. Biomed Res Int. 2014. PMID: 24949439 Free PMC article. Review.
-
Cilostazol effectively attenuates deterioration of albuminuria in patients with type 2 diabetes: a randomized, placebo-controlled trial.Endocrine. 2014 Mar;45(2):293-301. doi: 10.1007/s12020-013-0002-3. Epub 2013 Jun 18. Endocrine. 2014. PMID: 23775007 Clinical Trial.
-
Cell Adhesion Molecules in Schizophrenia Patients with Metabolic Syndrome.Metabolites. 2023 Mar 2;13(3):376. doi: 10.3390/metabo13030376. Metabolites. 2023. PMID: 36984816 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous